Joanna Klubo-Gwiezdzinska
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Joanna Klubo-Gwiezdzinska as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:24 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT06991738 · 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid CancerNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · not yet recruiting · Thyroid Cancer · principal investigator
- Ph2NCT04927416 · The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid CancerNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · recruiting · Metastic Thyroid Cancer · principal investigator
- Ph2NCT03841617 · The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid CancerNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · recruiting · Thyroid Cancer · principal investigator
- N/ANCT01109420 · Clinical and Genetic Studies in Familial Non-medullary Thyroid CancerNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · recruiting · Non-Medullary Thyroid Cancer · principal investigator
- Ph2NCT00054756 · Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary AbnormalitiesNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Healthy, Pituitary Disease, Thyroid Disease · principal investigator
- N/ANCT00001160 · Studies on Tumors of the ThyroidNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · recruiting · Hurthle Cell Thyroid Cancer, Tall Cell Variant Thyroid Cancer, Follicular Thyroid Cancer · principal investigator
- N/ANCT00001159 · Natural History of Thyroid Function DisordersNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · recruiting · Hyperthyroidism, Hypothyroidism, Grave's Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Application of molecular diagnostics in thyroid cancerZIADK075139 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · fiscal years 2017 to 2025 · $911,394 awarded in 2025Same name and institution; not confirmed by an ID
- Cross-talk between oncogene-driven signaling pathways and thyroid cancer metabolismZIADK075140 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · fiscal years 2017 to 2025 · $911,394 awarded in 2025Same name and institution; not confirmed by an ID
- Somatostatin receptors in the diagnosis and treatment of thyroid cancerZIADK075138 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · fiscal years 2017 to 2025 · $455,697 awarded in 2025Same name and institution; not confirmed by an ID
- Studies of Benign and Malignant Thyroid DiseaseZIADK047053 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · fiscal years 2021 to 2025 · $607,596 awarded in 2025Same name and institution; not confirmed by an ID
- Studies of Thyroid Function in Health and DiseaseZIEDK075005 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · fiscal years 2017 to 2024 · $93,441 awarded in 2024Same name and institution; not confirmed by an ID
- Studies of Benign and Malignant Thyroid DiseaseZIEDK047053 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · fiscal years 2017 to 2020 · $116,903 awarded in 2020Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 13:24 UTC. The ranking covers the 200 most relevant of 3 PubMed records, and a shared surname and initials can bring in a namesake. All 3 on PubMed
- Combined Immunosuppressive Therapy Induces Remission in Patients With Severe Type B Insulin Resistance: A Prospective Cohort Study.Diabetes Care · 201836 citationsRCR 1.3
- Phase II Study of 177Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and Biomarkers.J Clin Oncol · 202521 citationsRCR 6.6
- A Novel Risk Stratification System for Thyroid Nodules With Indeterminate Cytology-A Pilot Cohort Study.Front Endocrinol (Lausanne) · 20207 citationsRCR 0.5